[Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication].
Als-Nielsen
Bodil E
BE
H:S Rigshospitalet, Copenhagen Trial Unit, Center for klinisk interventionsforskning. bodil.a@ctu.rh.dk
Gluud
Lise Lotte
LL
Gluud
Christian N
CN
D006801:Humans; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006501:Hepatic Encephalopathy / Q000188:drug therapy; D007408:Intestinal Absorption / Q000187:drug effects; D007792:Lactulose / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use; D013402:Sugar Alcohols / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; C014635:lactitol; D007792:Lactulose; D009355:Neomycin; D013402:Sugar Alcohols